Introduction Many older people presenting to Acute Medical Units are - - PowerPoint PPT Presentation

introduction
SMART_READER_LITE
LIVE PREVIEW

Introduction Many older people presenting to Acute Medical Units are - - PowerPoint PPT Presentation

JRF Gladman 1 , JA Edmans 1 , L Bradshaw 1 , SP Conroy 2 1 Division of Rehabilitation and Ageing, University of Nottingham, UK 2 Geriatric Medicine, University Hospitals of Leicester/University of Leicester, UK Simon Conroy: spc3@leicester.ac.uk


slide-1
SLIDE 1

JRF Gladman1, JA Edmans1, L Bradshaw1, SP Conroy2

1 Division of Rehabilitation and Ageing, University of Nottingham, UK 2 Geriatric Medicine, University Hospitals of Leicester/University of Leicester, UK

Simon Conroy: spc3@leicester.ac.uk Judi Edmans: judi.edmans@nottingham.ac.uk

“This presentation presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10147). The views expressed in this presentation are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.”

slide-2
SLIDE 2

Introduction

 Many older people presenting to Acute Medical Units are

discharged after only a short stay (< 72 hours)

 Many re-present to hospital or die within 1 year  Specialist geriatric medical management and short term

case management may improve patient outcomes for older patients identified as being at high risk of readmission, functional decline or death

  • To evaluate the effect of geriatrician input on the outcomes
  • f high risk older people discharged from acute medical

assessment units

slide-3
SLIDE 3

Methods

 Patients aged >/=70, discharged from two UK AMUs  Scoring >/=2 on the Identification of Seniors at Risk tool  Randomised to receive specialist geriatric medical

assessment and after care, or usual care

 Follow up by postal questionnaire 90 days after

randomisation

 Outcomes included mortality, institutionalisation,

dependency in activities of daily living (ADL), mental well- being, quality of life and falls

slide-4
SLIDE 4

Measures

 Baseline

 Demographics  ISAR score  Health conditions: presenting problems, co-morbidities (Charlson co-

morbidity index) and list of medications

 Cognitive function: Folstein Mini-Mental State Examination (MMSE)  Personal activities of daily living (ADL): Barthel ADL Index  Health related quality of life/status: EuroQoL EQ5D  Psychological well-being: General Health Questionnaire 12 (GHQ-12)

 Follow up

 Primary outcome: days at home  Secondary outcomes: mortality, institutionalisation, dependency, mental

well-being, quality of life, and health and social care resource use.

slide-5
SLIDE 5

Intervention

 Assessment prior to discharge by geriatrician  Review of diagnoses and medication review  Further assessment at home or clinic or admission

recommended

 Advance care planning; liaison with primary care  Intermediate care and specialist community services  Intervention was expected to be complete within one

month of randomisation

slide-6
SLIDE 6

Assessed for eligibility (n=1001) Randomised (n=433) Not included n=568  Excluded n=190  Declined consent n=378 Allocated to control (n=217)  Received allocated intervention (n=216)  Did not receive allocated intervention (assessed by geriatrician) (n=1) Allocated to intervention (n=216)  Received allocated intervention (n=212)  Did not receive allocated intervention (not assessed by geriatrician) (n=4)  Withdrawn at baseline after initial consent from medical practitioner (n=5)  Dead at follow-up (n=12)  Withdrawn from clinical follow up (n=40)  Died between follow up date and ascertainment (n=3)  Withdrawn at baseline after initial consent from medical practitioner (n=11)  Dead at follow-up (n=14)  Withdrawn from clinical follow up (n=34)  Died between follow up date and ascertainment (n=1) Analysed for primary outcome and secondary outcomes of mortality, institutionalisation and hospital presentations (n=212) Questionnaire for other outcomes completed at 90 days (n=157)  No/incomplete information on GHQ-12 (n=25)  No/incomplete information on EQ5D (n=18)  No/incomplete information on ICECAP-O (n=37)  No information on falls (n=2) Analysed for primary outcome and secondary outcomes

  • f mortality, institutionalisation and hospital

presentations (n=205) Questionnaire for other outcomes completed at 90 days (n=156)  No/incomplete information on GHQ-12 (n=21)  No/incomplete information on EQ5D (n=10)  No/incomplete information on ICECAP-O (n=25) Enrolment Allocation Follow-Up Analysis

slide-7
SLIDE 7

Results

 Groups were well matched for baseline characteristics  Withdrawal rates were similar in both groups (5%)  At 90 days there were no significant differences in: mean days at home (80.2 days control v 79.7 days

intervention)

mortality (6% control v 7% intervention) proportion moving to care homes (3% both groups)

slide-8
SLIDE 8

Results

There were no differences in:

 Barthel ADL (median: 16, IQR 11 to 19 in each group, n=313)  GHQ 12 (median: control - 12.5, IQR 9 to 18; intervention:

12, IQR 9 to 17 intervention, n=267)

 EQ-5D (mean: 0.45, SD 0.32 both groups, n=285)  Proportion of participants who fell at 90 days (43% control

v 41% intervention n=311)

slide-9
SLIDE 9

Discussion

 Comorbidities were not common  Polypharmacy and cognitive impairment were present  Large proportion declined to give consent  Need better method of identifying high risk patients  Isolated specialist geriatric input across the acute –

community interface

 Need more sophisticated, integrated intervention

slide-10
SLIDE 10

Conclusions

 Isolated specialist geriatric medical input to high risk

patients discharged from AMUs made no difference to measures of:

 days at home  dependency in ADL  psychological well-being  quality of life  proportion of participants with a fall during the follow-

up period

slide-11
SLIDE 11

Baseline measurements